A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Nelson Essentials of Pediatrics
BACKGROUND: Heart failure (HF) is a common disease with complex pathophysiological causes. Diagnosis, risk assessment and treatment of HF are difficult and therefore there is a need for additional tools to improve clinical performance. Galectin-3 is a biomarker of inflammation and fibrosis, which is strongly associated with adverse remodeling and ventricular dysfunction. AIM: To evaluate the value of galectin-3 for prediction of HF among children with congenital heart diseases with left todoi:10.1016/b978-1-4377-0643-7.00143-1 fatcat:xxnqnhhdlbgx7dw45zbnwdx4va